Voluven 6% Injection 1's

VOLUVEN 6% INJECTION is used to treat hypovolemia. The detailed uses of VOLUVEN 6% INJECTION are as follows:

• Treatment of Hypovolemia:VOLUVEN 6% INJECTION treats hypovolemia by restoring blood volume in cases of severe bleeding or trauma.
• Intravenous Fluid Replacement:VOLUVEN 6% INJECTION helps restore lost plasma volume, prevent dehydration, and maintain body fluid balance through intravenous fluid replacement.

VOLUVEN 6% INJECTION belongs to the class of blood substitutes, plasma expanders, and electrolytes. It is used to treat hypovolemia in adults and children. VOLUVEN 6% INJECTION contains hydroxyethyl starch and sodium chloride. Hydroxyethyl starch helps to substitute body fluid by increasing blood volume and maintaining blood pressure. Sodium chloride helps to maintain body fluid balance by treating dehydration or electrolyte imbalances. Thus, VOLUVEN 6% INJECTION helps in plasma volume expansion, fluid balance maintenance, treatment of dehydration and electrolyte imbalances, and improved circulatory stability.

• Follow your doctor's instructions on the dosage and timing of this medication.
• VOLUVEN 6% INJECTION is administered by the doctor or healthcare professional.
• Do not self-administer.

• Drink more fluids to avoid dehydration.
• Limit sodium intake, as it may cause high blood pressure and fluid retention.
• Eat foods that help support blood volume and are rich in water, such as watermelon, cucumber, tomatoes, broccoli, spinach, oranges, Brussels sprouts, and apples. These foods support overall health and blood volume.
• Monitor your kidney and liver function, fluid balance, and electrolyte levels regularly.
•  Avoid alcohol and smoking consumption.

Inform your doctor before taking VOLUVEN 6% INJECTION if you are allergic to any of the VOLUVEN 6% INJECTION ingredients. Monitor for signs of hypersensitivity reactions, discontinuing use if such reactions occur. Avoid using it in patients with pre-existing renal dysfunction, and discontinue at the first sign of renal injury. In patients undergoing open heart surgery with cardiopulmonary bypass, monitor coagulation status and discontinue use at the first sign of coagulopathy due to reported excess bleeding. Be aware that elevated serum amylase values may occur, potentially interfering with the diagnosis of pancreatitis. Monitor closely on liver and kidney functions, serum electrolytes, and fluid balance to avoid negative complications. High doses of VOLUVEN 6% INJECTION may lead to dilution of blood components and reduction in hematocrit and coagulation factors. Dose adjustment is required for patients with cardiac or renal dysfunction. Inform your doctor if you are a pregnant or nursing woman before taking VOLUVEN 6% INJECTION.